Our top pick for
Beginners
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Ventyx Biosciences stock
Learn how to easily invest in Ventyx Biosciences stock.
Ventyx Biosciences Inc is a biotechnology business based in the US. Ventyx Biosciences shares (VTYX) are listed on the NASDAQ and all prices are listed in US Dollars. Ventyx Biosciences employs 31 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Ventyx Biosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VTYX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Ventyx Biosciences stock price (NASDAQ: VTYX)
Use our graph to track the performance of VTYX stocks over time.Ventyx Biosciences shares at a glance
Information last updated 2022-07-06.
| Latest market close | $13.50 |
|---|---|
| 52-week range | $9.50 - $26.00 |
| 50-day moving average | $15.24 |
| 200-day moving average | $15.51 |
| Wall St. target price | $39.71 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.77 |
Buy Ventyx Biosciences shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 5 of 5
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Ventyx Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ventyx Biosciences price performance over time
Historical closes compared with the close of $13.5 from 2022-07-05
| 1 week (2022-06-30) | 10.38% |
|---|---|
| 1 month (2022-06-07) | -15.57% |
| 3 months (2022-04-07) | 3.05% |
| 6 months (2022-01-07) | -11.01% |
| 1 year (2021-07-03) | N/A |
|---|---|
| 2 years (2020-07-03) | N/A |
| 3 years (2019-07-03) | N/A |
| 5 years (2017-07-03) | N/A |
Ventyx Biosciences financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -21.02% |
| Return on equity TTM | -60.26% |
| Profit margin | 0% |
| Book value | $5.11 |
| Market capitalisation | $686.5 million |
TTM: trailing 12 months
Ventyx Biosciences share dividends
We're not expecting Ventyx Biosciences to pay a dividend over the next 12 months.
Ventyx Biosciences overview
Ventyx Biosciences, Inc. , a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases which is in phase I clinical trials. In addition, the company develops CNS-penetrant NLRP3 inhibitors for the treatment of Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and multiple sclerosis. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.
Ventyx Biosciences in the news
Ventyx Biosciences Announces Positive Topline Phase 1 Data for its Peripheral NLRP3 Inhibitor VTX2735
Frequently asked questions
What percentage of Ventyx Biosciences is owned by insiders or institutions?Currently 4.749% of Ventyx Biosciences shares are held by insiders and 99.17% by institutions. How many people work for Ventyx Biosciences?
Latest data suggests 31 work at Ventyx Biosciences. When does the fiscal year end for Ventyx Biosciences?
Ventyx Biosciences's fiscal year ends in December. Where is Ventyx Biosciences based?
Ventyx Biosciences's address is: 662 Encinitas Boulevard, Encinitas, CA, United States, 92024 What is Ventyx Biosciences's ISIN number?
Ventyx Biosciences's international securities identification number is: US92332V1070
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert